Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation

Am Heart J. 1996 Jun;131(6):1214-6. doi: 10.1016/s0002-8703(96)90098-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amiodarone / administration & dosage
  • Amiodarone / adverse effects*
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / adverse effects*
  • Atrial Fibrillation / complications*
  • Humans
  • Infusions, Intravenous
  • Male
  • Ventricular Fibrillation / chemically induced*
  • Wolff-Parkinson-White Syndrome / complications
  • Wolff-Parkinson-White Syndrome / drug therapy*

Substances

  • Anti-Arrhythmia Agents
  • Amiodarone